NEW YORK — Opentrons Robotics today announced the largest expansion of its automation portfolio to date, launching four new OT-2 workstation products supporting popular applications, including NGS, PCR and protein purification. These launches build on the success of the OT-2 COVID-19 workstations, which have been used by hundreds of labs around the world to rapidly […]

Cardiff site will manufacture single-use bioprocessing technologies used to make vaccines and biopharmaceuticals for global customers. Part of a £300 million investment over two years with Pall Life Sciences into UK operations. Cytiva, a global life sciences leader, is opening a new 11 000 m² manufacturing facility in Cardiff, Wales. The site, part of a two […]

Tromsø, Norway – ArcticZymes Technologies ASA (OSE: AZT) announces the establishment of a new application development laboratory at ShareLab in Oslo. ArcticZymes Technologies has signed an agreement with ShareLab AS to lease laboratory facilities at its premises in the Oslo Science Park. These facilities will support application development activities to demonstrate the utility of the Company´s enzymes in customer relevant workflows and […]

STOCKHOLM — Tataa Biocenter AB, a leading European provider of molecular analysis services with ISO 17025 accreditation, is launching Olink® EXPLORE 3072 proteome profiling service. This new platform offers exceedingly high performance with unprecedented throughput based on Illumina sequencing technology. “Olink® EXPLORE 3072 is the perfect complement to our already optimized genomics and transcriptomics offerings and will be imperative […]

SOUTH SAN FRANCISCO, Calif. and REDWOOD CITY, Calif. – Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Kriya Therapeutics, Inc., a fully integrated company pioneering novel technologies and therapeutics in gene therapy, today announced an antibody discovery agreement for antibodies delivered using […]

Extends company capabilities into nanobody and antibody discovery and development. WALTHAM, MA – Fortis Life Sciences has acquired Abcore, a San Diego, California, USA based antibody discovery platform specializing in nanobody technology. With the addition of Abcore, Fortis extends its capabilities into the antibody discovery market serving biopharma customers developing antibody and nanobody-based therapeutics. Brian […]

Next-generation mid-pilot scale peptide synthesizer provides more reliable, robust, and improved workflows  Uppsala, Sweden: Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer. The new system is an upgraded version of the Company’s previous model, […]

License agreement provides Quanterix access to Lilly’s P-tau217 antibody technology, creating pathways for plasma-based biomarkers for use in Alzheimer’s disease; Establishes framework for future collaboration and supports development of Quanterix tests to advance diagnosing and treating life-threatening diseases Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision […]

Masoud Toloue, President of Quanterix and Diagnostics, to Become CEO and Join Board of Directors Kevin Hrusovsky, Chairman and CEO of Quanterix, to Assume Role as Executive Chairman of the Board Moves are Designed to Propel the Precision Health Vision and Catalyze the Next Chapter of Growth and Impact Billerica, Mass. – Quanterix Corporation (NASDAQ: QTRX), […]